All AbMole products are for research use only, cannot be used for human consumption.
DRB18 is a pan-GLUT (glucose transporters) inhibitor that inhibits growth and proliferation in several different cancer cells. DRB18 can eventually lead to G1/S phase arrest and increase oxidative stress and necrotic cell death.
| Molecular Weight | 382.88 |
| Formula | C22H23ClN2O2 |
| CAS Number | 2863686-81-9 |
| Solubility (25°C) | DMSO 40 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related GLUT Products |
|---|
| STF-31
STF-31 is a selective glucose transporter GLUT1 inhibitor, with an IC50 of 1 μM. STF-31 is also a NAMPT inhibitor. |
| WZB117
WZB117 is an inhibitor of Glucose Transporter 1 (GLUT1). It inhibited cell proliferation in lung cancer A549 cells and breast cancer MCF7 cells with an IC50 of approximately 10 μM. |
| 1,9-Dideoxyforskolin
1,9-Dideoxyforskolin is a inactive analog of forskolin |
| Dihydrokainic acid
Dihydrokainic acid is a selective inhibitor of the GLT-1 glutamate transporter. |
| BAY-876
BAY-876 is a potent, highly selective, cell-permeable inhibitor of glucose transporter GLUT1 with an IC50 of 2 nM. BAY-876 is also a potent blocker of glycolytic metabolism and ovarian cancer growth. BAY-876 can induce the formation of disulfide bonds in actin cytoskeletal proteins, leading to the occurrence of cellular disulfidptosis. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
